ArticleAnnals of medicine2026
Placental transport dysfunction in omega-3 and omega-6 fatty acid in patients with gestational diabetes mellitus.
Article in Annals of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGestational diabetes mellitus (GDM) affects the transfer of fatty acid (FA) from mother to fetus. However, the specific transport alterations remain unclear. This study investigated FA transport from mother to fetus in GDM.
methodsMaternal serum, umbilical cord serum, and placental tissues were collected from 20 healthy (normal group) and 20 GDM pregnancies receiving glycemic management (GDM group). Fifty-one FA were quantified by gas chromatography-mass spectrometry. Placenta/mother and fetus/placenta ratios of FA compositions were compared between groups using Student's t-test or Mann-Whitney U test, as appropriate.
resultsThe concentrations and compositions of FA profiles were both changed in GDM. The placenta/mother ratios of cis-11,14,17-eicosatrienoic acid (GDM vs normal: 0.648 vs 0.484,
conclusionsFA profiles in mother, placenta, and fetus were affected by GDM despite glycemic management, especially in omega-3 and omega-6 LC PUFAs. This finding indicates that addressing fetal FA deficiency may depend on correcting placental dysfunction rather than solely increasing maternal FA supplementation, offering insights for developing nutritional and therapeutic strategies for GDM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.